Clinical Trial Update: A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document details an ongoing Phase 1/2 clinical trial evaluating cobolimab in combination with dostarlimab in pediatric and young adult cancers. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma
• Ependymoma
• Glioblastoma
• Hepatocellular Carcinoma
• Hodgkin Lymphoma
• Melanoma
• Osteosarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Cobolimab (cobolimab)
• JEMPERLI (DOSTARLIMAB)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Melanoma, Hodgkin Lymphoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING